Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 48: 1539-1545, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanson, N. Q.
Right arrow Articles by Tsai, M. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanson, N. Q.
Right arrow Articles by Tsai, M. Y.
Related Collections
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2002;48:1539-1545.)
© 2002 American Association for Clinical Chemistry, Inc.

Interlaboratory Variation of Plasma Total Homocysteine Measurements: Results of Three Successive Homocysteine Proficiency Testing Surveys

Naomi Q. Hanson1, John H. Eckfeldt1, Kerry Schwichtenberg1, Ömer Aras1 and Michael Y. Tsai1a

1 Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN 55455.

aAddress correspondence to this author at: 420 Delaware St., SE Mayo Mail Code 609, Minneapolis, MN 55455-0392. Fax: 612-625-5622; e-mail tsaix001{at}tc.umn.edu.

Background: Numerous studies have demonstrated that increased plasma total homocysteine (tHcy), whether measured after fasting or after a methionine load, is associated with increased risk for cardiovascular and thromboembolic diseases. However, little information is available regarding interlaboratory variation of tHcy measurements, especially at the increased tHcy concentrations observed after loading.

Methods: We conducted three Homocysteine Proficiency Testing Surveys at 6-month intervals. Sets of five plasma pools with endogenous tHcy concentrations ranging from 5 to 48 µmol/L were sent to participants. We received 11, 23, and 17 responses in the first, second, and third surveys, respectively. The following methods were used by participating laboratories: fluorescence polarization immunoassay (FPIA); HPLC with fluorescent detection (HPLC-FD), further subdivided by type of reduction/derivatization; HPLC with electrochemical detection (HPLC-ED); amino acid analyzer with ninhydrin detection; and liquid chromatography–electrospray tandem mass spectrometry (LC-MS/MS).

Results: In surveys 1 and 2, no notable differences among the mean tHcy values obtained by the different methods performed were observed. In survey 3, tHcy values obtained by the FPIA method were significantly lower (P <0.05) at increased tHcy concentrations (34 µmol/L) compared with values obtained by HPLC-FD regardless of reduction/derivatization agents used. Our laboratory confirmed the observation that tHcy values obtained by the FPIA method differed from those obtained by HPLC-FD at increased tHcy concentrations by reanalyzing each pool 10 times by FPIA and HPLC-FD using tributylphosphine–ammonium 7-fluoro-2,1,3-benzoxadiazole-4-sulfonate (P <0.001 for tHcy >19 µmol/L). The mean among-method variations in surveys 1, 2, and 3 were 19%, 12%, and 9.6%, respectively. When results of the three surveys were combined, the mean among-method variation on 170 samples was 13%. Within-method variation was lowest for the FPIA method (4.4%), and ranged from 11–20% for HPLC methods.

Conclusions: Various degrees of imprecision and lack of correlation among tHcy methods indicate that there is a need to improve analytical precision, decrease analytical difference, and standardize tHcy measurements among laboratories.




The following articles in journals at HighWire Press have cited this article:


Home page
 Obstet GynecolHome page
L. E. Mignini, P. M. Latthe, J. Villar, M. D. Kilby, G. Carroli, and K. S. Khan
Mapping the Theories of Preeclampsia: The Role of Homocysteine
Obstet. Gynecol., February 1, 2005; 105(2): 411 - 425.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. J. Huijgen, F. P.W. Tegelaers, C. H.H. Schoenmakers, C. J. Pronk-Admiraal, and S. Ekema
Multicenter Analytical Evaluation of an Enzymatic Method for the Measurement of Plasma Homocysteine and Comparison with HPLC and Immunochemistry
Clin. Chem., May 1, 2004; 50(5): 937 - 940.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Arndt, B. Guessregen, A. Hohl, and B. Heicke
Total Plasma Homocysteine Measured by Liquid Chromatography-Tandem Mass Spectrometry with Use of 96-Well Plates
Clin. Chem., April 1, 2004; 50(4): 755 - 757.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. Refsum, A. D. Smith, P. M. Ueland, E. Nexo, R. Clarke, J. McPartlin, C. Johnston, F. Engbaek, J. Schneede, C. McPartlin, et al.
Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion
Clin. Chem., January 1, 2004; 50(1): 3 - 32.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.